n this contribution, we investigated whether surface-enhanced Raman scattering (SERS) of serum can be a candidate method for detecting “luminal A” breast cancer (BC) at different stages. We selected three groups of participants aged over 50 years: 20 healthy women, 20 women with early localized small BC, and 20 women affected by BC with lymph node involvement. SERS revealed clear spectral differences between these three groups. A predictive model using principal component analysis (PCA) and linear discriminant analysis (LDA) was developed based on spectral data, and its performance was estimated with cross-validation. PCA-LDA of SERS spectra could distinguish healthy from BC subjects (sensitivity, 92 %; specificity, 85 %), as well as subjects with BC at different stages, with a promising diagnostic performance (sensitivity and specificity, ≥80 %; overall accuracy, 84 %). Our data suggest that SERS spectroscopy of serum, combined with multivariate data analysis, represents a minimally invasive, easy to use, and fast approach to discriminate healthy from BC subjects and even to distinguish BC at different clinical stages.

SERS analysis of serum for detection of early and locally advanced breast cancer

SERGO, VALTER;BONIFACIO, ALOIS
2015

Abstract

n this contribution, we investigated whether surface-enhanced Raman scattering (SERS) of serum can be a candidate method for detecting “luminal A” breast cancer (BC) at different stages. We selected three groups of participants aged over 50 years: 20 healthy women, 20 women with early localized small BC, and 20 women affected by BC with lymph node involvement. SERS revealed clear spectral differences between these three groups. A predictive model using principal component analysis (PCA) and linear discriminant analysis (LDA) was developed based on spectral data, and its performance was estimated with cross-validation. PCA-LDA of SERS spectra could distinguish healthy from BC subjects (sensitivity, 92 %; specificity, 85 %), as well as subjects with BC at different stages, with a promising diagnostic performance (sensitivity and specificity, ≥80 %; overall accuracy, 84 %). Our data suggest that SERS spectroscopy of serum, combined with multivariate data analysis, represents a minimally invasive, easy to use, and fast approach to discriminate healthy from BC subjects and even to distinguish BC at different clinical stages.
Pubblicato
https://link-springer-com.units.idm.oclc.org/article/10.1007/s00216-015-8923-8
File in questo prodotto:
File Dimensione Formato  
Breast_cancer.pdf

accesso aperto

Descrizione: final version at doi 10.1007/s00216-015-8923-8
Tipologia: Bozza finale post-referaggio (post-print)
Licenza: Copyright Editore
Dimensione 623.6 kB
Formato Adobe PDF
623.6 kB Adobe PDF Visualizza/Apri
SERS analysis of serum for detection of early and locally advanced breast cancer.pdf

non disponibili

Descrizione: PDF versione editoriale
Tipologia: Documento in Versione Editoriale
Licenza: Copyright Editore
Dimensione 951.09 kB
Formato Adobe PDF
951.09 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
216_2015_8923_MOESM1_ESM.pdf

non disponibili

Descrizione: Electronic supplementary material
Tipologia: Altro materiale allegato
Licenza: Copyright Editore
Dimensione 306.7 kB
Formato Adobe PDF
306.7 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11368/2870766
Citazioni
  • ???jsp.display-item.citation.pmc??? 11
  • Scopus 58
  • ???jsp.display-item.citation.isi??? 52
social impact